Cardiac biomarkers beyond heart disease?

Leukemia Research

Volumn 35, Issue 6, 2011, Pages 703-704

  Monsuez, Jean Jacques ^a  

^a Hopital Rene Muret Bigottini   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE P38; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; B CELL LYMPHOMA; CARDIOMYOPATHY; CORONARY ARTERY DISEASE; EDITORIAL; HEART DISEASE; HEART FAILURE; HEART HYPERTROPHY; HEART LEFT VENTRICLE FAILURE; HUMAN; LARGE CELL LYMPHOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PULMONARY HYPERTENSION;

BIOLOGICAL MARKERS; FEMALE; HEART DISEASES; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS;

EID: 79955599884     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2011.02.002     Document Type: Editorial

References (11)

1. Daniels L.B., Maisel A.S. Natriuretic peptides. J Am Coll Cardiol 2007, 50:2357-2368.
2. Braunwald E. Biomarkers in heart failure. N Engl J Med 2008, 358:2148-2159.
3. Kuwahara K., Nakao K. Regulation and significance of atrial and brain natriuretic peptides as cardiac hormones. Endocrine J 2010, 57:555-565.
4. Sandri M.T., Salvatici M., Cardinale D., Zorzino L., Passerini R., Lentati P. N-terminal pro-B-type natriuretic peptide after high-dose chemotherapy: a marker predictive of cardiac dysfunction?. Clin Chem 2005, 51:1405-1410.
5. Gimeno E., Gomez M., Gonzalez J.R., Comin J., Alvarez-Laran A., Sanchez-Gonzalez B. NT-proBNP: a cardiac biomarker to assess prognosis in non-Hodgkin lymphoma. Leuk Res 2011, 35:715-720.
6. Skinnider B.F., Mak T.W. The role of cytokines in classical Hodgkin lymphoma. Blood 2002, 99:4283-4297.
7. Biggar R.J., Johansen J.S., Ekström Smedby K., Roosgaart K., Chang ET., Adami HO. Serum YKL-40 and IL-6 levels in Hodgkin lymphoma. Clin Cancer Res 2008, 14:6974-6978.
8. Niitsu N., Okamato M., Nakamine H., Yoshino T., Tamaru J., Nakamura S. Simultaneous elevation of the serum concentrations of vascular endothelial growth factor and interleukin-6 as independent predictors of prognosis in aggressive non-Hodgkin's lymphoma. Eur J Haematol 2002, 68:91-100.
9. Seymour J.F., Talpaz M., Cabanillas F., Wetzler L., Kurzrock R. Serum interleukin-6 levels correlate with prognosis in diffuse large-cell lymphoma. J Clin Oncol 1995, 13:373-382.
10. Pedersen L.M., Jürgensen G.W., Johnsen H.E. Serum levels of inflammatory cytokines at diagnosis correlate to the bcl-6 and CD10 defined germinal centre phenotype and bcl-2 expression in patients with diffuse large B-cell lymphoma. Br J Haematol 2005, 128:813-819.
11. Meldrum D.R. Tumor necrosis factor in the heart. Am J Physiol 1998, 274:R577-R595.